Abstract Cycad seed consumption by the native islanders of Guam is frequently associated with high rates of amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS/PDC); furthermore, accompanying pathological examination often exhibits a-synuclein inclusions in the neurons of the affected brain. Acylated steryl-b-glucoside (ASG) contained in cycad seeds is considered as causative environmental risk factor. We aimed to investigate whether ASG influences aggregation and cell toxicity of a-synuclein. To understand whether ASG is a causative factor in the development of ALS/PDC, soybean-derived ASG was tested for its effect on in vitro aggregation of a-synuclein using Thioflavin-T. ASG was also tested to determine whether it modulates a-synuclein cytotoxicity in yeast cells. In addition, we determined whether an interaction between ASG and a-synuclein occurs in the plasma membrane or cytoplasm using three factors: GM1 ganglioside, small unilamellar vesicles, and ATP. In the present study, we found that ASG-mediated acceleration of a-synuclein aggregation is influenced by the presence of ATP, but not by the presence of GM1. ASG accelerated the a-synuclein aggregation in the cytoplasm. ASG also enhanced a-synuclein-induced cytotoxicity in yeast cells. This study demonstrated that ASG directly enhances aggregation and cytotoxicity of a-synuclein, which are often observed in patients with ALS/PDC. These results, using assays that replicate cytoplasmic conditions, are consistent with the molecular mechanism that cytotoxicity is caused by intracellular a-synuclein fibril formation in neuronal cells.
Introduction
Amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS/PDC) is a unique neurodegenerative disease. It is remarkable that ALS and PDC, either in isolation or in combination occur with a high frequency in the Chamorro people of Guam, Kii Peninsula of Japan, and west New Guinea [1] [2] [3] [4] . The etiology of ALS/PDC has led to a growing awareness of the involvement of purely genetic and/or environmental factors. A potential environmental factor that has been considered to be involved in the etiology of ALS/PDC is the consumption of traditional foods made from flour of the cycad seed (Cycas micronesica), which has often been used as a primary foodstuff, especially during periods of famine [3] [4] [5] . Strong epidemiological data links disease development to cycad seed consumption. Cycad seeds are harvested, cut open to expose the starchy endosperm, sliced into 'chips', and then washed for periods of up to 10 days. Components of cycad seeds, particularly, steryl-b-glucosides including acylated steryl-b-glucoside (ASG in Fig. 1 ) and beta-N-methylamino-L-alanine (BMAA) have been focused upon as to their neurotoxicity [6, 7] . ASG and BMAA have been considered the principal components of cycad neurotoxin, a conclusion that is supported by a feeding experiment in CD1 mice [8, 9] . However, BMAA induces acute toxicity in mice, making it difficult to explain the overall symptoms of ALS/ PDC. Moreover, it has been shown that cycads were not used for food in two other high-incidence epicenters: Kii Peninsula and west New Guinea. In addition, ASG is generally found in many other edible plants in addition to cycads, and is consumed as a primary ordinary foodstuff all over the world; hence a particular genetic background of patients cannot be ignored in an etiological study of ALS/ PDC [8] . Thus, we hypothesize that ASG might be an environmental risk factor contributing to the pathogenesis of ALS/PDC, which is caused or affected both by genetic and environmental component. PDC in Guam is characterized by a marked loss of neurons and deposition of numerous neurofibrillary tangles (NFTs) in the neocortex, hippocampus, amygdale, and brainstem [10] . Significant a-synuclein deposition is observed in the amygdalae. These direct observations of the intracerebral pathology of ALS/ PDC led us to examine whether ASG may induce a-synuclein aggregation. Protein misfolding of a-synuclein causes a-synuclein fibril formation in the cytoplasm of neuronal cells, subsequently leading to neurotoxicity of progressing severity [11] . To demonstrate the potential relationship between ASG and a-synuclein fibril formation in the cytoplasm, we first tested for ASG's effect on aggregation of normal human a-synuclein by the use of an assay system replicating the in vitro conditions of a human subject. We then examined the growth of transformed yeast cells by a-synuclein in the presence or absence of ASG.
Materials and Methods

Materials
The following chemicals were purchased from Sigma Chemical Co. (St. Louis, MO): 1, 2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC); normal human a-synuclein (recombinant, expressed in Escherichia coli, N-terminal histidine-tagged); and Thioflavin-T (Th T). Acylated sterylb-glucoside (derived from soybean) was purchased from Matreya. GM1 ganglioside was purified from bovine brain according to a procedure we previously established [12] .
Preparation of Small Unilamellar Vesicles (SUVs) by Sonication SUVs (GM1-SUV and SUV) including GM/DPPC and DPPC alone were prepared by sonication following previously published methods [13] . Briefly, GM1/DPPC (molar ratio 1:1, unless otherwise noted) and DPPC alone were prepared at 10-20 mg/ml lipid per ml solvent (chloroform/methanol (2:1, v/v) by sonication. The solvent was evaporated using a dry nitrogen or argon stream in a fume hood. The lipid film was thoroughly dried to remove residual organic solvent by subjecting the vial or flask to a vacuum pump overnight. The thin film was hydrated in 100 mM NaCl and 20 mM Tris buffer (pH 7.4) with gentle mixing. Hydrated samples were then sonicated at 4°C with a probe sonicator for 4 min of 10 s pauses following 10 s sonication periods. Prior to assay, SUVs were mixed with monomeric a-synuclein. The SUV/a-synuclein mixture was adjusted by a 10:1 mass ratio of lipid to protein.
Analysis of a-Synuclein Fibril Formation
To induce fibrillization [14] , a-synuclein protein (80 lM) was incubated in either the presence (20 lg/ml) or absence of ASG in KHM buffer (40 mM HEPES-KOH, pH 7.4; 150 mM KCl; 20 mM MgCl 2 ; 1 mM dithiothreitol) plus ATP (10 mM) and an ATP regeneration system (20 mM creatine phosphate and 0.001 mg/ml creatine kinase) [15] . The sampling took place for time periods varying from 0-48 h at 37°C with 80 rotations per minute on a Minirotator (Glas-Col, LLC, Terre Haute, IN). Every 8 h, reactions were supplemented with a fresh ATP regeneration system to maintain ATP levels.
Fibril amount was determined by ThT fluorescence. ThT in 50 mM glycine (pH 8.5) was added to reach final concentrations of 0.25 lM a-synuclein and 10 lM ThT. Fluorescence at 485 nm was measured after excitation at 450 nm [16] .
Effect of ASGs on a-Synuclein Cytotoxicity Saccharomyces cerevisiae W303 (MATa ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1-100) was transformed using one of two plasmids. The first, plasmid p2HGPD, is an empty vector (control) while the second, p423GPD a-synuclein-YFP, allows for consistent expression of asynuclein-YFP under the GPD promoter [17] . The plasmid transformed cells were streaked onto histidine (SC-H)-free synthetic medium and incubated for 3 days at 30°C. ASG was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 5 mg/ml, and 100 ll of the solution was streaked onto SC-H plates to achieve a final concentration of 20 lg/ml. To address the toxicity of a-synuclein with ASG, cells were grown on SC-H for 1 day at 30°C then resuspended in water at 10 7 cells/ml by adjusting to 1.0 value at OD 600 . The cell suspensions were serially diluted (1:10), and 4 ll of each dilution was spotted onto 2 plates of different media (SC-H and SC-H including 20 lg/ml ASG) and incubated for 2 days at 30°C.
Electron Microscopy
Twenty microliters of reaction mixture was spread on a 200 mesh carbon-formvar coated grid, and allowed to stand about 60 s and then negatively stained with 15 ll of 1% (W/V) uranyl acetate for 20 s. The sample was examined by a high-performance, high contrast, 40-120 kV transmission electron microscope (JEOLJEM-1,230, JEOL Ltd, Tokyo Japan).
Statistical Analysis
Unless otherwise stated, results are presented as mean ± SE. Assays were performed in triplicate. The experimental data were analyzed using one-way ANOVA, followed by Tukey's multiple comparison test and Dunnet's test. Statistical analyzes were performed using the GraphPad Prism 5.0 software package (GraphPad, San Diego, CA, USA).
Results
Time Course for a-Synuclein Fiber Formation
ATP is needed for a-synuclein aggregation in the cytoplasm. This necessity is illustrated by our finding that the presence of ATP remarkably enhanced a-synuclein aggregation (Fig. 2a) , while in the absence of ATP, a-synuclein aggregation showed only beginning levels of kinetics, even after 48 h incubation. ASG showed no effect on a-synuclein aggregation. On the other hand, the presence of ATP increased a-synuclein aggregation up to 140% as compared with aggregation in the absence of ATP. This finding implicates that ASG-induced aggregation in the cytoplasm causes enough fibril formation to lead to cytotoxicity. In contrast, SUV affected a-synuclein aggregation, but ASG did not influence a-synuclein aggregation in the presence of SUV (Fig. 2b) . Additionally, GM1-SUV remarkably suppressed a-synuclein aggregation as compared with SUV; however, ASG-induced a-synuclein aggregation did not occur in the presence of GM1-SUV. This finding implies that ASG is not effective in regions or circumstances, such as the plasma membrane, in which GM1 is located abundantly.
Various factors involved in the plasma membrane and cytoplasm were examined as to their effect on ASGinduced a-synuclein aggregation (Fig. 3a) . The presence of ATP or ATP plus SUV affected ASG-induced a-synuclein aggregation with a significant statistical difference (*P \ 0.01). ASG-induced aggregation was enhanced further by the presence of ATP and SUV as compared with only ATP. Furthermore, to determine whether the interaction between various cytoplasmic factors and ASG-induced a-synuclein aggregation occurs in a time-dependent manner, a-synuclein incubation was extended up to 96 h (Fig. 3b) . After increasing for the first 48 h of incubation, Fig. 2 Effect of ASG on a-synuclein fibril formation in the presence of a 10 mM ATP or b GM1-SUV (or SUV). The mixture of a-synuclein (80 lM) was incubated at 37°C for 48 h with 80 rotations per minute. In (a) and (b), 20 ll of the aliquot was periodically taken from the incubating mixture, which was subsequently refilled to the same volume with either KMH buffer or ATP regeneration sytem (20 mM creatinine phosphate and 0.1 mg/ml creatine kinase) or only KMH buffer. The 20 ll aliquot samples were dispensed into 96-well microtiter plates (white plate with clear bottom, Corning) and mixed with 80 ll of 20 lM Th T in 50 mM glycine buffer (pH 8.5). Th T fluorescence was quantitated by a Perkin-Elmer Victor V multilabel plate reader with excitation/emission filters set at 450/485 nm the aggregation plateaued at 72 and 96 h. In summarizing these findings, there is no intrinsic difference between a-synuclein aggregation in either the plasma membrane or cytoplasm. Our experiment was able to reconstitute conditions of both compartments. The result was interpreted by varying degrees of aggregation by appearance. ASGinduced a-synuclein aggregation was independent of additive factors after 96 h incubation (Fig. 3b) . This finding suggests that ASG enhances a-synuclein aggregation but does not change the ultimate endpoint level of a-synuclein aggregates.
ASG-Induced a-Synuclein's Cytotoxicity
The a-synuclein-expressing cells displayed a marked reduction in cell growth compared with vector-expressing cells on the control plate (Fig. 4) . On the ASG plate, 20 lg/ml of ASG-treatment caused a-synuclein-expressing cells to exhibit a remarkable decreased growth as compared with non-treated cells on the control plate.
Electron Microscopy
The specimen was uniform except it was aggregated. Electron micrograph shows that the reaction mixture with ASG included a lot of relatively big aggregates consisting of fine filaments and other vesicle-derived lipid components in the a-synuclein aggregate (Fig. 5) .
Discussion a-Synuclein was originally found as the precursor of the non-Ab component of amyloid in brains from Alzheimer's disease (AD) patients. Subsequently, a-synuclein was found in fibril inclusions as components of Lewy bodies in Parkinson's disease and multiple system atrophy [18, 19] . Under normal conditions, the native structure of a-synuclein is an unfolded monomer reversibly equilibrated to a-helix form. This form of a-synuclein allows the molecule Fig. 3 Effects of various factors and incubation time on ASGinduced a-synuclein aggregate formation. a effects of various intracellular and extracellular factors on ASG-induced a-synuclein aggregate formation. a-synuclein (80 lM) was incubated at 37°C for 48 h in KHM buffer plus one of the following: no additive; 10 mM ATP; 0.8 mM SUV; 10 mMATP/0.8 mM SUV; 0.8 mM GM1-SUV; or 10 mM ATP/0.8 mM GM1-SU. Following incubation, samples were subjected to Th T fluorescence quantitation assay, as described in ''Materials and Methods''. (b) effect of incubation time of ASGinduced a-synuclein aggregation The incubated mixture was prepared as described in part (a) but incubation time was extended from 48 to 96 h Fig. 4 Effects of ASGs on the growth of serially diluted (1:10) yeast cells (strain W303 expressing p2HGDP and p423GDPa-synuclein genes), and 4 ll of each dilution was spotted onto 2 plates of different media (SC-H and SC-H including 20 lg/ml ASG) and incubated for 2 days at 30°C Fig. 5 Electron micrograph of a-synuclein filaments in ASG-induced a-synuclein aggregate. The reaction mixture containing 80 lM a-synuclein protein, 20 lg/ml of ASG, and 10 mM ATP was incubated at 37°C for 48 h, with ATP supplementation by the regeneration system. Arrows indicate fine filaments in the aggregate to associate with the surface phospholipids of vesicle membranes. Both this membrane interaction and an increased concentration of a-synuclein can facilitate the formation of a-synuclein dimers in the membrane or in the cytoplasm. Through dimerization, a-synuclein adopts a b-sheet secondary structure, and the membranes associate with a-synuclein monomers or other dimers, leading to oligomer formation. These oligomers in turn lead to fibril formation when they are deposited as amyloid in Lewy bodies causing Lewy neuritis [11] .
Consumption of a certain compound found in the cycad seeds traditionally used for food by the natives of Guam is assumed to be the risk factor responsible for ALS/PDC being a unique neurological disorder found in that population [1] [2] [3] [4] [5] . Steryl glucosides such as ASG have been proposed as the cycad neurotoxin of ALS/PDC [20] . Recently, various biological activities of ASG have been reported. These activities, namely anti-diabetic [21, 22] , analgesic [23] , and anti-hemolytic [24] activities as well as association with macrophage activation [25] , implicate ASG as having potential medical use. However, when considering the side effects of ASG, it is important for us to know the relevance of ASG to the ALS/PDC disease state.
The core of our hypothesis is that ASG-induced a-synuclein aggregation causes cytotoxicity. A new finding in our study was that soybean-derived ASG stimulates aggregation of normal human a-synuclein (Fig. 2) and that subsequent increases in the cytoplasmic concentration of a-synuclein led to cell toxicity. Although the extracellular or plasma membarane functions of a-synuclein remain unknown, the cytoplasmic function of a-synuclein has been clarified. In most of the studies, increased intracellular a-synuclein led to increased aggregate localization and sympathetic nerve membrane binding. In the cytoplasm, ATP is known to be a factor for triggering a-synuclein aggregation [26] . In our present experiment, ASG induced a remarkable enhancement of a-synuclein aggregation in the presence of ATP and SUV, but produced no effect on aggregation in the absence of ATP and SUV (Figs. 2a, 3a) . Additionally, ASG-induced a-synuclein aggregation did not occur in the presence of GM1-SUV (Fig. 3a) . Recently, GM1 was shown to be a mediator in certain essential signaling pathways of the nervous system and other tissues by interactions between GM1 and proteins. The interaction between GM1 and a-synuclein has been focused on Parkinson's disease and shown in animal studies [27, 28] . GM1 is localized mostly to a lipid raft within the plasma membrane. This raft associates with a-synuclein binding in a manner that promotes a-helical conformation and prevents pathological cytoplasmic fibrillation [29] . Thus, we suggest ASG works by enhancing a-synuclein aggregation in the cytoplasm.
In summary, the results of this study have demonstrated that ASG enhances in vitro a-synuclein aggregation leading to increased cell toxicity via cytoplasmic a-synuclein.
